Company: BIAF
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024163
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 0
---
bioAffinity
Technologies, Inc.

Condensed
Consolidated Balance Sheets

    June 30, 2025  
    December 31, 2024 

    (unaudited)  

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $802,835  
    $1,105,291 
  
    Accounts and other receivables, net 
     421,869  
     1,139,204 
  
    Inventory 
     43,971  
     27,608 
  
    Prepaid expenses and other current assets 
     400,151  
     422,995 
  
    Total current assets 
     1,668,826  
     2,695,098 

    Non-current assets: 

    Property and equipment, net 
     351,368  
     375,385 
  
    Operating lease right-of-use asset, net 
     399,879  
     463,011 
  
    Finance lease right-of-use asset, net 
     167,730  
     780,872 
  
    Goodwill 
     1,404,486  
     1,404,486 
  
    Intangible assets, net 
     745,972  
     775,139 
  
    Other assets 
     12,814  
     19,676 

    Total assets 
    $4,751,075  
    $6,513,667 

    LIABILITIES AND STOCKHOLDERS’ EQUITY  (DEFICIT) 

    Current liabilities: 

    Accounts payable 
    $1,169,837  
    $987,311 
  
    Accrued expenses 
     1,048,034  
     1,398,722 
  
    Unearned revenue 
     24,404  
     24,404 
  
    Operating lease liability, current portion 
     133,239  
     127,498 
  
    Finance lease liability, current portion 
     179,844  
     395,301 
  
    Notes payable, current portion 
     32,946  
     171,669 
  
    Total current liabilities 
     2,588,304  
     3,104,905 

    Non-current liabilities: